Literature DB >> 33478427

Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.

Fangyue Chen1, Emad Sidhom2, Sharon Yang3, Eladia Ruiz-Mendoza4, Julius Essem3.   

Abstract

BACKGROUND: Major depressive disorder and associated mood syndromes are amongst the most common psychiatric disorders. To date, electroconvulsive therapy (ECT) is considered the most effective short-term treatment for patients with severe or treatment-resistant depression. In clinical practice, there is considerable variation in the ECT dosing schedule, with the number of sessions typically ranging from 6 to 12, with early antidepressant effects being predictive of increased positive outcomes. We describe here an unusual case of a female patient with severe depression who did not respond to ECT until the 11th session, after which she had shown a drastic improvement in her mental state. CASE
PRESENTATION: A 75-year-old female presented to the old age psychiatry inpatient unit with new onset dysphoric mood, anhedonia, and severe negativity. She scored 23 on the 17-item Hamilton Rating Scale for Depression (HAM-D), and was rated 6 on Clinical Global Impression severity (CGIS) by the responsible clinician. She suffered from post-natal depression fifty years ago and was successfully treated with ECT. She was therefore initiated on a course of ECT treatment. Her condition initially deteriorated, displaying features of catatonia and psychosis, unresponsive to ECT treatment or concurrent psychotropic medications. After 11th ECT session, she started to show signs of clinical improvement and returned close to her baseline mental state after a total of 17 ECT sessions. She remained well 3 months post-treatment, scoring 4 on HAM-D, Clinical Global Improvement or change (CGI-C) rated as 1 (very much improved). The diagnosis was ICD-10 F32.3 severe depressive episode with psychotic symptoms.
CONCLUSIONS: we describe here an unusual case of delayed response to electroconvulsive therapy in the treatment of severe depressive disorder. Studies have shown the number of acute ECT treatments to be highly variable, affected by a number of factors including treatment frequency, condition treated and its severity, the ECT technical parameters, as well as concurrent use of pharmacological treatment. This may call for re-consideration of the current ECT treatment guidelines, requiring more research to help stratify and standardize the treatment regime.

Entities:  

Keywords:  Delayed response; Electroconvulsive therapy; Major depressive disorder; Standard treatment regime

Year:  2021        PMID: 33478427      PMCID: PMC7818214          DOI: 10.1186/s12888-021-03053-0

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  22 in total

1.  Clinical effectiveness and speed of response of electroconvulsive therapy in treatment-resistant schizophrenia.

Authors:  Christopher Yi Wen Chan; Edimansyah Abdin; Esmond Seow; Mythily Subramaniam; Jianlin Liu; Chao Xu Peh; Phern Chern Tor
Journal:  Psychiatry Clin Neurosci       Date:  2019-06-01       Impact factor: 5.188

2.  Electroconvulsive therapy stimulus titration: Not all it seems.

Authors:  Stephen J Rosenman
Journal:  Aust N Z J Psychiatry       Date:  2017-12-05       Impact factor: 5.744

3.  Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.

Authors:  Ching-Hua Lin; Ming-Chao Chen; Wei-Cheng Yang; Hsien-Yuan Lane
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-11       Impact factor: 4.600

4.  A novel augmentation strategy for treating resistant major depression.

Authors:  R C Shelton; G D Tollefson; M Tohen; S Stahl; K S Gannon; T G Jacobs; W R Buras; F P Bymaster; W Zhang; K A Spencer; P D Feldman; H Y Meltzer
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

5.  Predicting efficacy of electroconvulsive therapy in major depressive disorder.

Authors:  Kounosuke Tsuchiyama; Haruo Nagayama; Kumiko Yamada; Koichi Isogawa; Satomi Katsuragi; Akio Kiyota
Journal:  Psychiatry Clin Neurosci       Date:  2005-10       Impact factor: 5.188

Review 6.  What was learned: studies by the consortium for research in ECT (CORE) 1997-2011.

Authors:  M Fink
Journal:  Acta Psychiatr Scand       Date:  2014-02-12       Impact factor: 6.392

7.  Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.

Authors:  Marco Solmi; Nicola Veronese; Leonardo Zaninotto; Marc L M van der Loos; Keming Gao; Ayal Schaffer; Catherine Reis; Claus Normann; Ion-George Anghelescu; Christoph U Correll
Journal:  CNS Spectr       Date:  2016-10       Impact factor: 3.790

Review 8.  Management of Treatment-Resistant Depression: Challenges and Strategies.

Authors:  Daphne Voineskos; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

9.  Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study.

Authors:  Pichai Ittasakul; Siraprapha Vora-Arporn; Punjaporn Waleeprakhon; Phern-Chern Tor
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-04       Impact factor: 2.570

Review 10.  Pharmacological Treatments for Patients with Treatment-Resistant Depression.

Authors:  Valerie L Ruberto; Manish K Jha; James W Murrough
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.